126 related articles for article (PubMed ID: 9127460)
1. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster JY; Hejgaard J; Frøokiaer H; Christiansen C
Scand J Clin Lab Invest; 1997 Feb; 57(1):73-83. PubMed ID: 9127460
[TBL] [Abstract][Full Text] [Related]
2. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.
Srivastava AK; MacFarlane G; Srivastava VP; Mohan S; Baylink DJ
Calcif Tissue Int; 2001 Dec; 69(6):327-36. PubMed ID: 11800229
[TBL] [Abstract][Full Text] [Related]
3. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption.
Bonde M; Fledelius C; Qvist P; Christiansen C
Clin Chem; 1996 Oct; 42(10):1639-44. PubMed ID: 8855148
[TBL] [Abstract][Full Text] [Related]
4. Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.
Rosenquist C; Fledelius C; Christgau S; Pedersen BJ; Bonde M; Qvist P; Christiansen C
Clin Chem; 1998 Nov; 44(11):2281-9. PubMed ID: 9799755
[TBL] [Abstract][Full Text] [Related]
5. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
Garnero P; Gineyts E; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.
Christgau S; Rosenquist C; Alexandersen P; Bjarnason NH; Ravn P; Fledelius C; Herling C; Qvist P; Christiansen C
Clin Chem; 1998 Nov; 44(11):2290-300. PubMed ID: 9799756
[TBL] [Abstract][Full Text] [Related]
7. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis.
Garnero P; Delmas PD
Bone; 2003 Jan; 32(1):20-6. PubMed ID: 12584032
[TBL] [Abstract][Full Text] [Related]
8. Collagen type II C-telopeptide fragments as an index of cartilage degradation.
Christgau S; Garnero P; Fledelius C; Moniz C; Ensig M; Gineyts E; Rosenquist C; Qvist P
Bone; 2001 Sep; 29(3):209-15. PubMed ID: 11557363
[TBL] [Abstract][Full Text] [Related]
9. Immunoassay for quantifying type I collagen degradation products in urine evaluated.
Bonde M; Qvist P; Fledelius C; Riis BJ; Christiansen C
Clin Chem; 1994 Nov; 40(11 Pt 1):2022-5. PubMed ID: 7955372
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical performance of the immunoenzymometric assays for N-terminal and C-terminal type I collagen telopeptides and the HPLC assay for pyridinium cross-links.
Bettica P; Masino M; Cucinotta E; Vago T; Norbiato G; Moro L; Suarez KN; Romanello M; Bevilacqua M
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):63-8. PubMed ID: 9156570
[TBL] [Abstract][Full Text] [Related]
11. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
Bonde M; Garnero P; Fledelius C; Qvist P; Delmas PD; Christiansen C
J Bone Miner Res; 1997 Jul; 12(7):1028-34. PubMed ID: 9200001
[TBL] [Abstract][Full Text] [Related]
12. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
[TBL] [Abstract][Full Text] [Related]
13. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine.
Hanson DA; Weis MA; Bollen AM; Maslan SL; Singer FR; Eyre DR
J Bone Miner Res; 1992 Nov; 7(11):1251-8. PubMed ID: 1466251
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of the Elecsys beta-CrossLaps serum assay, a new assay for degradation products of type I collagen C-tlopeptides.
Okabe R; Nakatsuka K; Inaba M; Miki T; Naka H; Masaki H; Moriguchi A; Nishizawa Y
Clin Chem; 2001 Aug; 47(8):1410-4. PubMed ID: 11468230
[TBL] [Abstract][Full Text] [Related]
15. Serum osteocalcin and urinary crosslaps are suitable markers of bone turnover in response to short-term hormone replacement therapy.
Peichl P; Griesmacher A; Müller MM; Marteau R; Kumpan W; Bröll H
Gynecol Endocrinol; 2000 Oct; 14(5):374-81. PubMed ID: 11109977
[TBL] [Abstract][Full Text] [Related]
16. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
Taga M; Uemura T; Minaguchi H
J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
[TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum.
Srivastava AK; Bhattacharyya S; Castillo G; Miyakoshi N; Mohan S; Baylink DJ
Bone; 2000 Oct; 27(4):529-33. PubMed ID: 11033448
[TBL] [Abstract][Full Text] [Related]
18. Binding potency of peptide fragments of type 1 collagen cross-linked N-telopeptide measured by an enzyme-linked immunosorbant assay.
Lung FD; Chen CH; Chen HY; Liou CC; Liou YM
Protein Pept Lett; 2002 Oct; 9(5):451-7. PubMed ID: 12370034
[TBL] [Abstract][Full Text] [Related]
19. Development and application of a serum C-telopeptide and osteocalcin assay to measure bone turnover in an ovariectomized rat model.
Srivastava AK; Bhattacharyya S; Castillo G; Wergedal J; Mohan S; Baylink DJ
Calcif Tissue Int; 2000 Jun; 66(6):435-42. PubMed ID: 10821880
[TBL] [Abstract][Full Text] [Related]
20. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]